Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Aortech International Plc LSE:AOR London Ordinary Share GB0033360586 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 126.50 123.00 130.00 0.00 0.00 - 0.00 01:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 0.5 -0.6 -4.7 - 20

Aortech Share Discussion Threads

Showing 8501 to 8522 of 8900 messages
Chat Pages: Latest  344  343  342  341  340  339  338  337  336  335  334  333  Older
DateSubjectAuthorDiscuss
03/3/2020
12:24
Unusual for me bones; so happy that I’ve added a few more today! Unfortunately it’s not the 26k... Gla
andyview
03/3/2020
10:57
Good timing it would seem Andyview! Someone just weighed in with 26k at 93p paying well over the timed quote of 82-90. Have to hope the market steadies in general now.
bones
02/3/2020
08:51
I've long been an admirer here and so finally added an initial stake.. gla
andyview
28/2/2020
23:03
Biomerics has now kindly tweeted the short interview with Bill Brown that Landy90 posted a few days ago (post 3277): https://twitter.com/biomerics/status/1233419525762232322?s=21
bones
28/2/2020
17:56
On the plus side the volatility may lead to palpitations increaing demand for our products
the stigologist
23/2/2020
23:41
Interesting that Aortech appears to have a Frankfurt Stock Exchange quotation in Euros, albeit no trading activity, under the ticker AOHA. I wonder if this has any significance (I haven’t a clue!): Https://markets.ft.com/data/equities/tearsheet/summary?s=AOHA:FRA
bones
23/2/2020
18:11
TMK... "A quality company like AorTech International and nothing!" That is not entirely correct. A casual search on Twitter for "AORTech" produces a little more than 'nothing'. In fact a lot more! hTTps://twitter.com/search?q=AORtech&;src=typed_query You could also try #AOR although that produces all sorts of other rubbish mixed in with what we are interested in!
cybernest53
23/2/2020
17:43
No mention of heart-valves in the interview though !!
parsons4
23/2/2020
16:35
TMK, let’s get to 300p before the twitterati get a hold of it :)
bones
23/2/2020
14:45
mikeh30, I hope it isn't SPAM! TMK
tees maar khan
23/2/2020
14:14
TMK - check your inbox
mikeh30
23/2/2020
14:03
Good afternoon All, I really am surprised the discussion around AOR has not hit the Twitter folks? Random people with large followings who on a daily basis hashtag tickers w/complete nonsense most of the time and that stuff actually goes viral! A quality company like AorTech International and nothing! There's plenty subtle stuff going on in the background. Great video interview, landy90. Thanks for sharing that. TMK
tees maar khan
22/2/2020
15:07
hTTps://m.youtube.com/watch?v=prbjGfkayjs Bill Brown at MD&M with Biomerics
landy90
22/2/2020
13:23
Investors and others who may not be versed in the finer details of what Aortech is doing and its progress in the last year could do a lot worse than read pages 5 to 9 of the 2019 published financial statements. You can access those here: Https://www.aortech.net/wp-content/uploads/2019/07/Aortech-Annual-Report-July-2019.pdf
bones
21/2/2020
12:21
Cheers landy - a good start for them would be to set up a twitter handle and put up the odd tweet. These small things can make a big difference - imo.
someuwin
21/2/2020
12:02
Someuwin AorTech has kept very quiet these last few years as historically the old team over promised and under delivered to both the industry and markets. I read the ED note as a start of repositioning the company and would not be surprised to see other activities over the next few months.
landy90
21/2/2020
11:16
Cheers bones that was what I thought. I just wondered if Foldax had something else I'd missed. I guess they're just further down the line than us and, dare I say it, better at self promotion? AOR do seem to keep their light under a bushel.
someuwin
21/2/2020
10:55
Someuwin, I think other contributors on this thread have a better handle on the technicalities of your question but, from what I can glean, Foldax (which is run by ex-Aortech CEO, Frank Maguire) uses what might be described as an older iteration of the polymer technology but have gone to market first with that “design freeze”. Whereas Aortech have spent the last year using the latest computer aided fluid flow tools and generally re-engineered the manufacturing process in a way that, in design at least, overcomes speed and quality issues of the earlier designs. Hopefully, Aortech will have a superior product ultimately which can be produced at an industrial scale leading to materially cheaper unit costs. This is my layman’s understanding, so don’t take as gospel, and it is all subject to testing at many stages yet.
bones
21/2/2020
09:04
Re Edwards Lifesciences.....I haven't checked mkt. caps (to allow for share issues) but share price of the latter was just under 11$ in 2008 and peaked at just over 240$ in late 2019. Current mkt. cap is just under 49bn$.
langland
21/2/2020
08:59
What exactly is Foldax's USP and how does that compare to our heart valve design?
someuwin
21/2/2020
08:57
'Sponsored by Abbott'
the stigologist
21/2/2020
08:51
Foldax presenting some clinical trial data next Monday: https://twitter.com/foldax_tria/status/1230612383569104897?s=21
bones
Chat Pages: Latest  344  343  342  341  340  339  338  337  336  335  334  333  Older
ADVFN Advertorial
Your Recent History
LSE
AOR
Aortech
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200704 19:46:23